How do you incorporate next gen sequencing results into your management of pediatric patients with B-ALL who have not been transplanted?
With the new COG leukemia studies, it is difficult to interpret these results in the context of their clinical status and conventional MRD
Community PollStarted
For a patient with B-ALL, do you act upon positive next gen sequencing when MRD is below the level of clinical detection?
3 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · M.D. Anderson Cancer Center
Answered on
We enroll in the EndRAD SCT trial which is guided by NGS results.
Join for free or sign in to see the full answer